Patrice M Becker
Overview
Explore the profile of Patrice M Becker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
450
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pickering H, Schaenman J, Phan H, Maguire C, Tsitsiklis A, Rouphael N, et al.
Nat Commun
. 2025 Jan;
16(1):586.
PMID: 39794319
Coronavirus disease 2019 (COVID-19) poses significant risks for solid organ transplant recipients, who have atypical but poorly characterized immune responses to infection. We aim to understand the host immunologic and...
2.
Gaberino C, Altman M, Gill M, Bacharier L, Gruchalla R, OConnor G, et al.
J Allergy Clin Immunol
. 2025 Jan;
PMID: 39788435
Background: Determining why some upper respiratory illnesses provoke asthma exacerbations remains an unmet need. Objective: We sought to identify transcriptome-wide gene expression changes associated with colds that progress to exacerbation....
3.
Wang K, Nie Y, Maguire C, Syphurs C, Sheen H, Karoly M, et al.
bioRxiv
. 2024 Dec;
PMID: 39651165
Hospitalized COVID-19 patients exhibit diverse immune responses during acute infection, which are associated with a wide range of clinical outcomes. However, understanding these immune heterogeneities and their links to various...
4.
Maguire C, Chen J, Rouphael N, Pickering H, Phan H, Glascock A, et al.
bioRxiv
. 2024 Nov;
PMID: 39605478
Chronic viral infections are ubiquitous in humans, with individuals harboring multiple latent viruses that can reactivate during acute illnesses. Recent studies have suggested that SARS-CoV-2 infection can lead to reactivation...
5.
Gygi J, Maguire C, Patel R, Shinde P, Konstorum A, Shannon C, et al.
J Clin Invest
. 2024 May;
134(9).
PMID: 38690733
BACKGROUNDPatients hospitalized for COVID-19 exhibit diverse clinical outcomes, with outcomes for some individuals diverging over time even though their initial disease severity appears similar to that of other patients. A...
6.
Phan H, Tsitsiklis A, Maguire C, Haddad E, Becker P, Kim-Schulze S, et al.
Sci Transl Med
. 2024 Apr;
16(743):eadj5154.
PMID: 38630846
Age is a major risk factor for severe coronavirus disease 2019 (COVID-19), yet the mechanisms behind this relationship have remained incompletely understood. To address this, we evaluated the impact of...
7.
Wilson G, Knight J, Liu Q, Shelar A, Stewart E, Wang X, et al.
J Allergy Clin Immunol
. 2024 Mar;
154(2):297-307.e13.
PMID: 38485057
Background: MUPPITS-2 was a randomized, placebo-controlled clinical trial that demonstrated mepolizumab (anti-IL-5) reduced exacerbations and blood and airway eosinophils in urban children with severe eosinophilic asthma. Despite this reduction in...
8.
Phan H, Tsitsiklis A, Maguire C, Haddad E, Becker P, Kim-Schulze S, et al.
medRxiv
. 2024 Feb;
PMID: 38405760
Age is a major risk factor for severe coronavirus disease-2019 (COVID-19), yet the mechanisms responsible for this relationship have remained incompletely understood. To address this, we evaluated the impact of...
9.
Bunyavanich S, Becker P, Altman M, Lasky-Su J, Ober C, Zengler K, et al.
J Allergy Clin Immunol
. 2024 Jan;
153(4):954-968.
PMID: 38295882
Studies of asthma and allergy are generating increasing volumes of omics data for analysis and interpretation. The National Institute of Allergy and Infectious Diseases (NIAID) assembled a workshop comprising investigators...
10.
Ozonoff A, Jayavelu N, Liu S, Melamed E, Milliren C, Qi J, et al.
Nat Commun
. 2024 Jan;
15(1):216.
PMID: 38172101
Post-acute sequelae of SARS-CoV-2 (PASC) is a significant public health concern. We describe Patient Reported Outcomes (PROs) on 590 participants prospectively assessed from hospital admission for COVID-19 through one year...